Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, Gian Matteo Rigolin, Fabio Casciano, Maria Vittoria Arcidiacono, Claudio Celeghini, Antonio Cuneo, Giorgio Zauli, Paola Secchiero
Published Sep 20, 2016 · Vol. 7, No. 43 · pp. 70623-70638
Grazia Graziani, Federica Ruffini, Lucio Tentori, Manuel Scimeca, Annalisa S. Dorio, Maria Grazia Atzori, Cristina M. Failla, Veronica Morea, Elena Bonanno, Stefania D’Atri, Pedro M. Lacal
Published Sep 19, 2016 · Vol. 7, No. 45 · pp. 72868-72885
Michael Brooks, Qianxing Mo, Ross Krasnow, Philip Levy Ho, Yu-Cheng Lee, Jing Xiao, Antonina Kurtova, Seth Lerner, Gui Godoy, Weiguo Jian, Patricia Castro, Fengju Chen, David Rowley, Michael Ittmann, Keith Syson Chan
Published Sep 17, 2016 · Vol. 7, No. 50 · pp. 82609-82619